A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of EFRUXIFERMIN in Subjects with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

  • Pianko, Stephen (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date22/01/24 → 21/01/29